AC T00203
XX
ID T00203
XX
DT 25.01.1993 (created); ewi.
CO Copyright (C), QIAGEN.
XX
FA E1
XX
SY E1.
XX
OS BPV-1, bovine papilloma virus type 1
OC viridae; ds-DNA nonenveloped viruses; papovaviridae; papillomavirus
XX
SZ 605 AA; 68.1 kDa (calc.), 68.2 kDa
XX
SQ MANDKGSNWDSGLGCSYLLTEAECESDKENEEPGAGVELSVESDRYDSQDEDFVDNASVF
SQ QGNHLEVFQALEKKAGEEQILNLKRKVLGSSQNSSGSEASETPVKRRKSGAKRRLFAEXE
SQ ANRVLTPLQVQGEGEGRQELNEEQAISHLHLQLVKSKNATVFKLGLFKSLFLCSFHDITR
SQ LFKNDKTTNQQWVLAVFGLAEVFFEASFELLKKQCSFLQMQKRSHEGGTCAVYLICFNTA
SQ KSRETVRNLMANTLNVREECLMLQPAKIRGLSAALFWFKSSLSPATLKHGALPEWIRAQT
SQ TLNESLQTEKFDFGTMVQWAYDHKYAEESKIAYEYALAAGSDSNARAFLATNSQAKHVKD
SQ CATMVRHYLRAETQALSMPAYIKARCKLATGEGSWKSILTFFNYQNIELITFINALKLWL
SQ KGIPKKNCLAFIGPPNTGKSMLCNSLIHFLGGSVLSFANHKSHFWLASLADTRAALVDDA
SQ THACWRYFDTYLRNALDGYPVSIDRKHKAAVQIKAPPLLVTSNIDVQAEDRYLYLHSRVQ
SQ TFRFEQPCTDESGEQPFNITDADWKSFFVRLWGRLDLIDEEEDSEEDGDSMRTFTCSARN
SQ TNAVD
XX
SC translated from EMBL #X02346
XX
FT 1 129 
PF00524; E1 Protein, N terminal domain.
FT 166 596 
PF00519; Papillomavirus helicase.
XX
FF required for virus replication, targeted to origin of replication by complexing with E2;
XX
IN T00205 E2; BPV-1, bovine papilloma virus type 1.
XX
DR TRANSPATH: MO000024770.
DR EMBL: X02346;
DR UniProtKB: P03116;
XX
RN [1]; RE0002505.
RX PUBMED: 2251273.
RA Bradley D. W., Dou Q.-P., Fridovich-Keil J. L., Pardee A. B.
RT Transformed and nontransformed cells differ in stability and cell cycle regulation of a binding activity to the murine thymidine kinase promoter
RL Proc. Natl. Acad. Sci. USA 87:9310-9314 (1990).
RN [2]; RE0002509.
RX PUBMED: 1648739.
RA Lusky M., Fontane E.
RT Formation of the complex of bovine papillomavirus E1 and E2 proteins is modulated by E2 phosphorylation and depends upon sequences within the carboxyl terminus of E1
RL Proc. Natl. Acad. Sci. USA 88:6363-6367 (1991).
RN [3]; RE0002687.
RX PUBMED: 2176744.
RA Mohr I. J., Clark R., Sun S., Androphy E. J., MacPherson P., Botchan M. R.
RT Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator
RL Science 250:1694-1699 (1990).
XX
//